Describing the Biological Impacts of Gain-of-function SAMD9 Mutations |
Vanderbilt University Medical Center / Jason Schwartz, MD/PhD |
Young Investigator Grants |
2018 |
Tennessee |
Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
Adoptive Cell Therapy Targeting Antigen Escape Variants in Childhood High Grade Glioma |
Baylor College of Medicine / Meenakshi Hegde |
Young Investigator Grants |
2012 |
Texas |
Exploiting a Novel DNA Repair Defect in Ewing Sarcoma |
Dana-Farber Cancer Institute / Shuhei Asada, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Dissecting the Hierarchy of Tumor Cell Differentiation Using Dual Recombinase Technology in a Novel Mouse Model of Rhabdomyosarcoma |
Duke University Medical Center / David Van Mater, MD, PhD |
Young Investigator Grants |
2013 |
North Carolina |
Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model |
University of California San Francisco / Jean Nakamura |
Young Investigator Grants |
2011 |
California |
Ex Vivo Modeling of Medulloblastoma using Human iPSC-Derived Cerebellar Organoids |
St. Jude Children’s Research Hospital / Stephanie Wu, PhD |
Young Investigator Grants |
2023 |
Tennessee |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL |
University of Pennsylvania / Christian Hurtz, PhD |
Young Investigator Grants |
2018 |
Pennsylvania |
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis |
University of Minnesota / Beau Webber, PhD |
Young Investigator Grants |
2017 |
Minnesota |